Frequency of guideline-defined cow's milk allergy symptoms in infants: Secondary analysis of EAT trial data
- PMID: 34877731
- DOI: 10.1111/cea.14060
Frequency of guideline-defined cow's milk allergy symptoms in infants: Secondary analysis of EAT trial data
Abstract
Background: Non-IgE-mediated Cow's Milk Allergy (CMA) has a prevalence of less than 1% in children. Guidelines developed to help non-specialists diagnose CMA may lead to misattribution of normal symptoms and contribute to overdiagnosis of CMA. We sought to establish the frequency of symptoms during infancy associated with non-IgE-mediated CMA, using the international Milk Allergy in Primary Care (iMAP) guideline as representative of CMA guidelines more generally.
Method: Secondary analysis of the Enquiring About Tolerance (EAT) randomized controlled trial (ISRCTN 14254740; 1303 exclusively breastfed 3-month-old healthy infants). Key outcomes were ≥2 iMAP symptoms associated with 'mild-moderate' and 'severe' non-IgE-mediated CMA.
Results: Whilst breastfeeding and parental atopy rates were higher than the general population, participants were otherwise similar to the population of England and Wales. Two or more non-IgE CMA symptoms were reported by 25% families for mild-moderate and 1.4% for severe symptoms each month between ages 3 and 12 months, peaking at 38% with ≥2 mild-moderate and 4.3% ≥2 severe symptoms at three months, when participants were not directly consuming cow's milk. 74% of participants reported ≥2 mild-moderate symptoms and 9% ≥2 severe symptoms in at least one month during this period. At six months there was no evidence of difference in the proportion of children with ≥2 symptoms between those consuming (29.5% mild-moderate, 1.8% severe) and not consuming cow's milk (35.3% mild-moderate, 2.2% severe). Mean monthly reporting of ≥2 symptoms was also no different between those with (15.8% mild-moderate, 1.1% severe) or without eczema at baseline (16.7% mild-moderate, 1.3% severe).
Conclusions: Guideline-defined symptoms of non-IgE-mediated CMA are very common in infants. Guidelines may promote milk allergy overdiagnosis by labelling normal infant symptoms as possible milk allergy.
Keywords: atopic dermatitis; clinical immunology; epidemiology; food allergy; pediatrics.
© 2021 John Wiley & Sons Ltd.
Comment in
-
In response to Frequency of guideline-defined cow's milk allergy symptoms in infants: Secondary analysis of EAT trial data by Vincent et al.Clin Exp Allergy. 2022 Apr;52(4):581-582. doi: 10.1111/cea.14090. Epub 2022 Mar 30. Clin Exp Allergy. 2022. PMID: 34981585 Free PMC article. No abstract available.
References
REFERENCES
-
- Schoemaker AA, Sprikkelman AB, Grimshaw KE, et al. Incidence and natural history of challenge-proven cow's milk allergy in European children-EuroPrevall birth cohort. Allergy. 2015;70(8):963-972. doi:10.1111/all.12630
-
- Fiocchi A, Brozek J, Schunemann H, et al. World Allergy Organization (WAO) diagnosis and rationale for action against cow's milk allergy (DRACMA) guidelines. Pediatr Allergy Immunol. 2010;21(Suppl 21):1-125. doi:10.1111/j.1399-3038.2010.01068.x
-
- Munblit D, Perkin MR, Palmer DJ, Allen KJ, Boyle RJ. Assessment of evidence about common infant symptoms and cow’s milk allergy. JAMA Pediatrics. 2020;174(6):599-608.
-
- Venter C, Brown T, Meyer R, et al. Better recognition, diagnosis and management of non-IgE-mediated cow's milk allergy in infancy: iMAP-an international interpretation of the MAP (Milk Allergy in Primary Care) guideline. Clin Transl Allergy. 2017;7:26. doi:10.1186/s13601-017-0162-y
-
- Fox A, Brown T, Walsh J, et al. An update to the milk allergy in primary care guideline. Clin Transl Allergy. 2019;9(40):1-7.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources